4,546 resources
By Version
By Authority
By Realm
Start Prev Rows 2200 - 2400 Next
| Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth |
|---|---|---|---|---|---|---|---|---|---|
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-charlsonindex | CH CRL Observation Charlson Index | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-creasmangradingsystem | CH CRL Observation Creasman Grading System | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-dssplus | CH CRL Observation DSSplus | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-ebv | CH CRL Observation EBV | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-elstonellisgradingsystem | CH CRL Observation Elston/Ellis Grading System | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-figostaging | CH CRL Observation FIGO Staging | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-gleasonbiopsymostcommongrade | CH CRL Observation Gleason Biopsy Most Common Grade | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-gleasonbiopsy2ndmostcommonorhighestgrade | CH CRL Observation Gleason Biopsy Second Most Common or Highest Grade | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-gleasonexcisionmostcommongrade | CH CRL Observation Gleason Excision Most Common Grade | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-gleasonexcision2ndmostcommonorhighestgrade | CH CRL Observation Gleason Excision Second Most Common or Highest Grade | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-gleasonscore | CH CRL Observation Gleason Score | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-hpvp16 | CH CRL Observation HPV/p16 | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-her2receptorstatus | CH CRL Observation Her2 Receptor Status | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-iccc3code | CH CRL Observation ICCC-3 Code | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-iccc3extendedcode | CH CRL Observation ICCC-3 Extended Code | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-iccc3maingroup | CH CRL Observation ICCC-3 Main Group | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-icd10 | CH CRL Observation ICD-10 | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-icdo3behaviour | CH CRL Observation ICD-O-3 Behaviour | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-icdo3histologicalgrade | CH CRL Observation ICD-O-3 Histological Grade | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-icdo3laterality | CH CRL Observation ICD-O-3 Laterality | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-icdo3morphology | CH CRL Observation ICD-O-3 Morphology | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-icdo3morphologyposttransformation | CH CRL Observation ICD-O-3 Morphology Post-transformation | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-icdo3morphologypretransformation | CH CRL Observation ICD-O-3 Morphology Pre-transformation | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-icdo3topography | CH CRL Observation ICD-O-3 Topography | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-inrgssstaging | CH CRL Observation INRGSS Staging | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-irssstaging | CH CRL Observation IRSS Staging | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-issstaging | CH CRL Observation ISS Staging | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-ldh | CH CRL Observation LDH | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-luganostaging | CH CRL Observation Lugano Staging | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-pretextstaging | CH CRL Observation PRETEXT Staging | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-raistaging | CH CRL Observation Rai Staging | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-rhabdomyosarcomasitestaging | CH CRL Observation Rhabdomyosarcoma Site Staging | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-siopstaging | CH CRL Observation SIOP Staging | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-salzerkuntschikgradingsystem | CH CRL Observation SalzerKuntschik Grading System | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-shimadagradingsystem | CH CRL Observation Shimada Grading System | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-stjudemurphystaging | CH CRL Observation St. Jude / Murphy Staging | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-cm | CH CRL Observation cM | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-ct | CH CRL Observation cT | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-cn | CH CRL Observation cN | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-pm | CH CRL Observation pM | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-pt | CH CRL Observation pT | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-pn | CH CRL Observation pN | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-tnmstagegroup | CH CRL Observation TNM Stage Group | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-torontotierIImanualstaging | CH CRL Observation Toronto Tier II (Manual) Staging | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-whogradegroup | CH CRL Observation WHO Grade Group | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-whocnsgradingsystem | CH CRL Observation WHO(CNS) Grading System | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-aprefixofptnm | CH CRL Observation a-Prefix of pTNM | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-associatedinsitutumour | CH CRL Observation Associated In-situ Tumour | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-cvaortia | CH CRL Observation Cerebrovascular Accident or Transient Ischemic Attack | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-chronicpulmonarydisease | CH CRL Observation Chronic Pulmonary Disease | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-circumferentialresectionmargins | CH CRL Observation Circumferential Resection Margins | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-clinicaltumoursize | CH CRL Observation Clinical Tumour Size | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-congestiveheartfailure | CH CRL Observation Congestive Heart Failure | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-connectivetissuediseaserheumaticdisease | CH CRL Observation Connective Tissue Disease - Rheumatic Disease | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-dateofincidence | CH CRL Observation Date of Incidence | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-dementia | CH CRL Observation Dementia | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-diabetesmellitus | CH CRL Observation Diabetes Mellitus | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-hemiplegiaparaplegia | CH CRL Observation Hemiplegia / Paraplegia | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-liverdisease | CH CRL Observation Liver Disease | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-lymphaticinvasion | CH CRL Observation Lymphatic Invasion | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-msuffixofpt | CH CRL Observation m-Suffix of pT | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-metastasesatdiagnosisindicator | CH CRL Observation Metastases at Diagnosis Indicator | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-microsatelliteinstability | CH CRL Observation Microsatellite Instability | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-moderatetoseverechronickidneydisease | CH CRL Observation Moderate to Severe Chronic Kidney Disease | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-myocardialinfarction | CH CRL Observation Myocardial Infarction | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-numberexaminedregionallymphnodes | CH CRL Observation Number of Examined Regional Lymph Nodes | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-numberexaminedsentinellymphnodes | CH CRL Observation Number of Examined Sentinel Lymph Nodes | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-numberinvolvedregionallymphnodes | CH CRL Observation Number of Involved Regional Lymph Nodes | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-numberpositivesentinellymphnodes | CH CRL Observation Number of Positive Sentinel Lymph Nodes | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-oestrogenreceptorstatus | CH CRL Observation Oestrogen Receptor Status | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-pathologicaltumoursize | CH CRL Observation Pathological Tumour Size | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-pepticulcerdisease | CH CRL Observation Peptic Ulcer Disease | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-perineuralinvasion | CH CRL Observation Perineural Invasion | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-peripheralvasculardisease | CH CRL Observation Peripheral Vascular Disease | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-pretreatmentprostatespecificantigen | CH CRL Observation Pretreatment Prostate Specific Antigen | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-progesteronereceptorstatus | CH CRL Observation Progesterone Receptor Status | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-resectionmargininsitutumour | CH CRL Observation Resection Margin In-situ Tumour | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-resectionmargininvasivetumour | CH CRL Observation Resection Margin Invasive Tumour | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-residualinsitutumour | CH CRL Observation Residual In-situ Tumour | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-residualinvasivetumour | CH CRL Observation Residual Invasive Tumour | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-sentinellymphnodeassessment | CH CRL Observation Sentinel Lymph Node Assessment | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-serumtumourmarkers | CH CRL Observation Serum Tumour Markers | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-topographymetastasesatdiagnosis | CH CRL Observation Topography of Metastases at Diagnosis | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-topographypostdiagnosismetastases | CH CRL Observation Topography of Post-diagnosis Metastases | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-tumourproliferationlabeling | CH CRL Observation Tumour Proliferation Labeling | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-typerecurrencetransformation | CH CRL Observation Type of Recurrence/Transformation | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-venousinvasion | CH CRL Observation Venous Invasion | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-yprefixofctnm | CH CRL Observation y-Prefix of cTNM | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-yprefixofptnm | CH CRL Observation y-Prefix of pTNM | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-alphafetoprotein | CH CRL Observation α-fetoprotein | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-crl | R4 | ch-crl-observation-hcg | CH CRL Observation β-hCG | active | 2022-02 | ch | hl7 | ||
| ch.fhir.ig.ch-vacd | R4 | ch-vacd-laboratory-serology | CH VACD Laboratory And Serology | active | 2025-05 | ch | hl7 | ||
| ch.fhir.ig.ch-emed | R4 | ch-emed-observation-list | CH EMED Observation (LIST) | active | 2025-05 | ch | hl7 | ||
| ch.fhir.ig.ch-emed-epr | R4 | ch-emed-epr-observation-list | PML Observation | draft | 2025-01 | ch | hl7 | ||
| ch.fhir.ig.ch-emed-epr | R4 | ch-emed-epr-observation-body-weight | Body Weight Observation | draft | 2025-01 | ch | hl7 | ||
| ch.fhir.ig.ch-emed | R4 | ch-emed-observation | CH EMED Observation (PADV) | active | 2025-05 | ch | hl7 | ||
| ch.fhir.ig.ch-emed-epr | R4 | ch-emed-epr-observation | PADV Observation | draft | 2025-01 | ch | hl7 | ||
| nictiz.fhir.nl.r4.nl-core | R4 | nl-core-DevelopmentChild.ToiletTrainednessFeces | nl core DevelopmentChild.ToiletTrainednessFeces | draft | nl | ||||
| nictiz.fhir.nl.r4.zib2020 | R4 | zib-DevelopmentChild.ToiletTrainednessFeces | zib DevelopmentChild.ToiletTrainednessFeces | draft | nl | hl7 | |||
| nictiz.fhir.nl.r4.nl-core | R4 | nl-core-DevelopmentChild.ToiletTrainednessUrine | nl core DevelopmentChild.ToiletTrainednessUrine | draft | nl | ||||
| nictiz.fhir.nl.r4.zib2020 | R4 | zib-DevelopmentChild.ToiletTrainednessUrine | zib DevelopmentChild.ToiletTrainednessUrine | draft | nl | hl7 | |||
| hl7.fhir.us.breast-radiology | R4 | DensityAbnormality | Density Abnormality | active | 2022-12 | us | hl7 | ||
| MyHIE.v4-test | R4 | Observation-dental-alert-my-core | ObservationDentalAlertMyCore | active | 2023-09 | ||||
| IdHIE.0v | R4 | Observation-dental-alert-id-core | ObservationDentalAlertMyCore | active | 2023-06 | ||||
| hl7.fhir.us.military-service | R4 | deployment-history-episode | Deployment History Episode | active | 2023-05 | us | hl7 | ||
| rki.demis.laboratory.strict | R4 | PathogenDetectionACBP | Erregernachweis für Acinetobacter spp. bei Nachweis einer Carbapenemase-Determinante oder mit verminderter Empfindlichkeit gegenüber Carbapenemen außer bei natürlicher Resistenz; Meldepflicht nur bei Infektion oder Kolonisation. | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionADVP | Erregernachweis für Adenoviren; Meldepflicht nur für den direkten Nachweis im Konjunktivalabstrich | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionADEP | Erregernachweis für Adenoviren; Meldepflicht bei akuter Infektion für Nachweise aus allen Körpermaterialien | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionEAHP | Erregernachweis für Amoebiasis, Entamoeba histolytica | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionABVP | Erregernachweis für Arboviren (sonstige) | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionASTP | Erregernachweis für Astroviren | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionBANP | Erregernachweis für Bacillus anthracis | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionBPSP | Erregernachweis für Bordetella pertussis, Bordetella parapertussis | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionBORP | Erregernachweis für Borrelia recurrentis | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionBOBP | Erregernachweis für (Lyme-) Borreliose, Borrelia burgdorferi | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionBRUP | Erregernachweis für Brucella sp. | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionCAMP | Erregernachweis für Campylobacter spp. (darmpathogen) | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionCAUP | Erregernachweis für Candida auris; Meldepflicht nur für den direkten Nachweis | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionCKVP | Erregernachweis für Chikungunya-Virus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionCHLP | Erregernachweis für Chlamydia psittaci | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionCLOP | Erregernachweis für Clostridium botulinum oder Toxinnachweis | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionCORP | Erregernachweis für Corynebacterium spp. (Toxin bildend) | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionCOXP | Erregernachweis für Coxiella burnetii | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionCYMP | Erregernachweis für Cytomegalie, Cytomegalievirus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionDENP | Erregernachweis für Denguevirus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionEBVP | Erregernachweis für Ebolavirus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionEBCP | Erregernachweis für Enterobacterales bei Nachweis einer Carbapenemase-Determinante oder mit verminderter Empfindlichkeit gegenüber Carbapenemen außer bei natürlicher Resistenz; Meldepflicht nur bei Infektion oder Kolonisation | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionETVP | Erregernachweis für Enteroviren | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetection | Erregernachweis | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionHFAP | Erregernachweis für andere Erreger hämorrhagischer Fieber | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionWBKP | Erregernachweis für Krankheitserreger unter Berücksichtigung der Art der Krankheitserreger und der Häufigkeit ihres Nachweises wenn Hinweise auf eine schwerwiegende Gefahr für die Allgemeinheit bestehen | active | 2025-02 | de | |||
| demis.fhir.profiles | R4 | PathogenDetectionWBGP | Erregernachweis für die Meldepflicht von Krankheitserregern mit Hinweise auf eine schwerwiegende Gefahr für die Allgemeinheit | active | 2021-11 | ||||
| rki.demis.laboratory.strict | R4 | PathogenDetectionEHCP | Erregernachweis für Escherichia coli (enterohämorrhagische Stämme) (EHEC) | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionECOP | Erregernachweis für Escherichia coli (sonstige darmpathogene Stämme) | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionFSVP | Erregernachweis für FSME-Virus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionFRTP | Erregernachweis für Francisella tularensis | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionGBSP | Erregernachweis für Gruppe-B-Streptokokken (GBS); Meldepflicht nur für den direkten Nachweis bei Schwangeren und Neugeborenen | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionGFVP | Erregernachweis für Gelbfiebervirus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionGILP | Erregernachweis für Giardia lamblia | active | 2025-02 | de | |||
| de.medizininformatikinitiative.kerndatensatz.mtb | R4 | mii-pr-mtb-hrd-score | MII PR MTB HRD Score | draft | de | ||||
| rki.demis.laboratory.strict | R4 | PathogenDetectionHINP | Erregernachweis für Haemophilus influenzae; Meldepflicht nur für den direkten Nachweis aus Liquor oder Blut | active | 2025-02 | de | |||
| rki.demis.r4.core | R4 | PathogenDetectionHFMP | Erregernachweis für Hand-Fuß-Mund-Krankheit | active | 2023-05 | ||||
| rki.demis.laboratory.strict | R4 | PathogenDetectionHTVP | Erregernachweis für Hantavirus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionHAVP | Erregernachweis für Hepatitis-A-Virus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionHBVP | Erregernachweis für Hepatitis-B-Virus; Meldepflicht für alle Nachweise | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionHCVP | Erregernachweis für Hepatitis-C-Virus; Meldepflicht für alle Nachweise | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionHDVP | Erregernachweis für Hepatitis-D-Virus; Meldepflicht für alle Nachweise | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionHEVP | Erregernachweis für Hepatitis-E-Virus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionINVP | Erregernachweis für Influenzavirus; Meldepflicht nur für den direkten Nachweis | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionLSVP | Erregernachweis für Lassavirus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionLEGP | Erregernachweis für Legionella sp. | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionPLAP | Erregernachweis für Plasmodium spp. (Malaria) | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionMBVP | Erregernachweis für Marburgvirus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionMSVP | Erregernachweis für Masernvirus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionMRSP | Erregernachweis für Middle-East-Respiratory-Syndrome-Coronavirus (MERS-CoV) | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionMPXP | Erregernachweis für Mpoxvirus (Orthopockenviren) | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionMPVP | Erregernachweis für Mumpsvirus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionMYLP | Erregernachweis für Mycobacterium leprae | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionMYTP | Erregernachweis für Mycobacterium tuberculosis, Mycobacterium africanum, Mycobacterium bovis; Meldepflicht für den direkten Erregernachweis sowie nachfolgend für das Ergebnis der Resistenzbestimmung; vorab auch für den Nachweis säurefester Stäbchen im Sputum | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionMPMP | Erregernachweis für Mycoplasmen | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionNEIP | Erregernachweis für Neisseria meningitidis; Meldepflicht nur für den direkten Nachweis aus Liquor, Blut, hämorrhagischen Hautinfiltraten oder anderen normalerweise sterilen Substraten | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionNOVP | Erregernachweis für Norovirus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionPKVP | Erregernachweis für Orthopockenviren (Variolavirus) | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionOPXP | Erregernachweis für Orthopockenviren (sonstige Orthopockenviren) | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionPINP | Erregernachweis für Parainfluenzavirus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionPOVP | Erregernachweis für Poliovirus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionRBVP | Erregernachweis für Rabiesvirus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionRSVP | Erregernachweis für Respiratorisches-Synzytial-Virus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionRICP | Erregernachweis für Rickettsia prowazekii | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionPVBP | Erregernachweis für Ringelröteln, Parvovirus B 19 | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionRTVP | Erregernachweis für Rotavirus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionRUVP | Erregernachweis für Rubellavirus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionCVDP | Erregernachweis für Severe-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2) | active | 2025-02 | de | |||
| demis.fhir.profiles | R4 | PathogenDetectionSARSCoV2 | SARS-CoV-2-Erregernachweis | retired | 2021-03 | ||||
| rki.demis.laboratory.strict | R4 | PathogenDetectionSPAP | Erregernachweis für Salmonella Paratyphi; Meldepflicht für alle direkten Nachweise | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionSALP | Erregernachweis für Salmonella (sonstige) | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionSPYP | Erregernachweis für Scharlach, Beta-hämolysierenden Streptokokken der Gruppe A | active | 2025-02 | de | |||
| rki.demis.igs | R4 | PathogenDetectionSequence | Sequenz-Erregernachweis | active | 2024-07 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionCVSP | Erregernachweis für Severe-Acute-Respiratory-Syndrome-Coronavirus-1 (SARS-CoV-1) (2003) | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionSHIP | Erregernachweis für Shigella sp. | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionMRAP | Erregernachweis für Staphylococcus aureus (Methicillin-resistente Stämme); Meldepflicht nur für den Nachweis aus Blut oder Liquor | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionSPNP | Erregernachweis für Streptococcus pneumoniae; Meldepflicht nur für den direkten Nachweis aus Liquor, Blut, Gelenkpunktat oder anderen normalerweise sterilen Substraten | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionCLTP | Erregernachweis für Tetanus, Clostridium tetani | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionTRIP | Erregernachweis für Trichinella spiralis | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionVZVP | Erregernachweis für Varizella-Zoster-Virus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionVCHP | Erregernachweis für Vibrio cholerae | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionNCVP | Erregernachweis für Vibrio spp., humanpathogen (außer Erreger der Cholera); soweit ausschließlich eine Ohrinfektion vorliegt, nur bei Vibrio cholerae non O1/non-O139 | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionWNVP | Erregernachweis für West-Nil-Virus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionYPSP | Erregernachweis für Yersinia pestis | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionYENP | Erregernachweis für Yersinia spp. (darmpathogen) | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionZKVP | Erregernachweis für Zika-Virus | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionBOVP | Erregernachweis für humanpathogene Bornaviren; Meldepflicht nur für den direkten Nachweis | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionCRYP | Erregernachweis für humanpathogene Cryptosporidium sp. | active | 2025-02 | de | |||
| rki.demis.laboratory.strict | R4 | PathogenDetectionLEPP | Erregernachweis für humanpathogene Leptospira sp. | active | 2025-02 | de | |||
| healthdata.be.r4.dcd | R4 | HDBP0037-LaboratoryTestResult | HDBP0037 LaboratoryTestResult | draft | |||||
| hl7.fhir.cl.minsal.nid | R4 | MINSALSituacionDiscapacidad | MINSAL Situacion Discapacidad | draft | 2025-04 | cl | hl7 | ||
| nictiz.fhir.nl.r4.nl-core | R4 | nl-core-Wound.WoundEdge | nl core Wound.WoundEdge | draft | nl | ||||
| nictiz.fhir.nl.r4.zib2020 | R4 | zib-Wound.WoundEdge | zib Wound.WoundEdge | draft | nl | hl7 | |||
| nictiz.fhir.nl.r4.nl-core | R4 | nl-core-Wound.WoundMoisture | nl core Wound.WoundMoisture | draft | nl | ||||
| nictiz.fhir.nl.r4.zib2020 | R4 | zib-Wound.WoundMoisture | zib Wound.WoundMoisture | draft | nl | hl7 |
FHIR